Recursion Pharmaceuticals: Q2 Earnings Snapshot

Recursion Pharmaceuticals Inc. (RXRX) reported a second-quarter loss of $131 million, or 25 cents per share, exceeding Wall Street expectations of a 23-cent loss. The company's revenue of $7.7 million also fell short of analyst projections of $14.4 million.